Bafna Pharmaceuticals standalone net profit rises 93.68% in the December 2025 quarter
(12 Feb 2026)
Back
Net profit of Bafna Pharmaceuticals rose 93.68% to Rs 1.84 crore in the quarter ended December 2025 as against Rs 0.95 crore during the previous quarter ended December 2024. Sales rose 15.37% to Rs 38.29 crore in the quarter ended December 2025 as against Rs 33.19 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended | | Dec. 2025 | Dec. 2024 | % Var. |
| Sales | 38.29 | 33.19 | 15 |
| OPM % | 7.97 | 9.25 | - |
| PBDT | 3.41 | 2.62 | 30 |
| PBT | 1.84 | 0.96 | 92 |
| NP | 1.84 | 0.95 | 94 |
|